Literature DB >> 2520164

Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting.

M E Halloran, C J Struchiner, A Spielman.   

Abstract

Population effects of malaria vaccination programs will depend on the stage specificity of the vaccine, its duration of effectiveness, whether it is responsive to natural boosting, the proportion vaccinated, and the preexisting endemic conditions. This paper develops models of infection-blocking (sporozoite), disease-modifying (merozoite), and transmission-blocking (gametic) vaccines. It explores numerically their different effects on prevalence of infection and disease when utilized in different types of immunization programs at various levels of coverage. Simulations show that possible qualitative consequences of malaria vaccination programs include decreased prevalence of infection and disease and decreased prevalence of infection without a corresponding decrease in prevalence of disease. Epidemics, either one-time or cyclical, could occur. These effects could be accompanied by changes in the age distribution of disease. Finally, vaccination could contribute to elimination of transmission. The duration of effectiveness of the malaria vaccine relative to the duration of natural immunity could have important consequences for the unvaccinated. The problem of predicting a threshold for elimination of transmission is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2520164     DOI: 10.1016/0025-5564(89)90074-6

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  10 in total

Review 1.  The role of mathematical modeling in evidence-based malaria control.

Authors:  F Ellis McKenzie; Ebrahim M Samba
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

2.  Mastering malaria: what helps and what hurts.

Authors:  Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-10       Impact factor: 11.205

3.  One versus two doses: What is the best use of vaccine in an influenza pandemic?

Authors:  Laura Matrajt; Tom Britton; M Elizabeth Halloran; Ira M Longini
Journal:  Epidemics       Date:  2015-06-22       Impact factor: 4.396

4.  Discrete-Event Models of Mixed-Phenotype Plasmodium falciparum Malaria.

Authors:  F Ellis McKenzie; Roger C Wong; William H Bossert
Journal:  Simulation       Date:  1999       Impact factor: 1.377

5.  The Minicommunity Design to Assess Indirect Effects of Vaccination.

Authors:  M Elizabeth Halloran
Journal:  Epidemiol Methods       Date:  2012-08-01

6.  Challenges of evaluating and modelling vaccination in emerging infectious diseases.

Authors:  Zachary J Madewell; Natalie E Dean; Jesse A Berlin; Paul M Coplan; Kourtney J Davis; Claudio J Struchiner; M Elizabeth Halloran
Journal:  Epidemics       Date:  2021-10-05       Impact factor: 5.324

Review 7.  Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S.

Authors:  Katya Galactionova; Thomas A Smith; Melissa A Penny
Journal:  Malar J       Date:  2021-11-18       Impact factor: 2.979

8.  Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination.

Authors:  Laurent Coudeville; Geoff P Garnett
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

9.  Local scale prediction of Plasmodium falciparum malaria transmission in an endemic region using temperature and rainfall.

Authors:  Yazoumé Yé; Moshe Hoshen; Catherine Kyobutungi; Valérie R Louis; Rainer Sauerborn
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

10.  Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response.

Authors:  R R Dinglasan; J S Armistead; J F Nyland; X Jiang; H Q Mao
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.